#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pleural mesothelioma Sarcoma Phenylketonuria Anaplastic thyroid cancer Congenital nephrogenic diabetes insipidus Erdheim-Chester disease Gaucher's disease type III Hypertriglyceridaemia Liver abscess Cutaneous T-cell lymphoma refractory Acute myeloid leukaemia (in remission) Immunoglobulin G4 related disease Peripheral T-cell lymphoma unspecified Juvenile chronic myelomonocytic leukaemia Atopic keratoconjunctivitis More trials…

    Learn about Rare Diseases

    SAPHO syndrome – Trials in Disease Indolent systemic mastocytosis – Life with Disease Angelman’s syndrome – Basic Information Cystic fibrosis – Trials in Disease Mantle cell lymphoma stage IV – Treatment Sarcoma – Diagnostics Wiskott-Aldrich syndrome Familial haemophagocytic lymphohistiocytosis – Treatment Brain stem glioma Undifferentiated sarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    MAGNESIUM ACETATE TETRAHYDRATE Specific Nucleic Acid Sna-Her2 Rezvilutamide Vx-264 INSULIN DETEMIR Prasterone Sodium Oxybate Caffeine Ceftazidime Pentahydrate Teicoplanin Napabucasin Infigratinib WEF-001 Cloxacillin Sodium Romosozumab Eribulin Certolizumab Pegol Hydroxypropylbetadex VX-993 Proline More therapies…

    Learn about Your Condition

    Lip and/or oral cavity cancer Asthmatic crisis Giardiasis Muscle hypertrophy Myopia Migraine without aura Polymyositis Systemic infection Medulloblastoma recurrent Athetosis Familial mediterranean fever Bacterial prostatitis Acoustic neuroma Liposarcoma Epicondylitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Psychological Phenomena

  • Effect of atomoxetine on learning dynamics in healthy adults: a study comparing single dose atomoxetine 40 mg with placebo

    Recruiting

    2 1 1
    Investigated Drugs:
    • Gelatin
    • Atomoxetine
    France

  • Study on Improving Social Interaction in Children with Autism Using Oxytocin Nasal Spray and Therapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Oxytocin
    Belgium

  • Study on Oxytocin’s Effects on Trust and Learning in Healthy Children Using Nasal Spray

    Recruiting

    1 1 1
    Investigated Drugs:
    • Oxytocin
    Belgium

  • Study on ITI-1284 for Treating Agitation in Alzheimer’s Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Iti-1284
    Bulgaria Croatia Czechia Romania Slovakia Spain

  • Study on How Methylphenidate Works in Adults with ADHD, Comparing Those with and Without Obesity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    Investigated Drugs:
    • Methylphenidate Hydrochloride
    France

  • Study on the Effects of Escitalopram, Naltrexone, and Their Combination on Reducing Symptoms of Compulsive Sexual Behavior Disorder in Affected Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Compulsive sexual behaviour
    Investigated Drugs:
    • Escitalopram Oxalate
    • Naltrexone Hydrochloride
    Poland
1 2 3 … 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!